Why do pharmaceutical companies repeat the mistakes of Internet medical treatment in digital therapy?

Since the emergence of the concept of digital therapy, due to its unclear control of fees and improvement of medical service capabilities, this model is not most interested in insurance and medical service providers, but pharmaceutical companies

In this context, pharmaceutical companies have been looking for health management tools that can cooperate with them in the past ten years

The main goal of pharmaceutical companies is to increase their own drug sales.

Since online consultations on third-party platforms are essentially corporate welfare, the utilization rate has been hovering around 10% for a long time, and the growth of consultations has been very limited

The situation of online health management is similar to that of online consultation

Moreover, health management is essentially a means for the payer to control expenses.

Of course, it is precisely because online consultation and health management are corporate benefits, users are separated from doctors, and digital therapy hopes to promote patients to get one-stop solutions from doctors

Although the solution provided by digital therapy seems to be perfect, users also get the supplementary treatment plan when they get the medicine.

Secondly, digital therapy can only be paid by companies and insurance companies.

Finally, pharmaceutical companies can be the payer by themselves.

Therefore, although pharmaceutical companies seem to have a perfect solution in the field of digital therapy, they actually ignore the contradiction between digital therapy’s inhumanity, accessibility, and payers, and the fact that pharmaceutical companies cannot become payers.